These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Evaluation of several dosing regimens of cefepime, with various simulations of renal function, against clinical isolates of Pseudomonas aeruginosa in a pharmacodynamic infection model. Cappelletty DM. Antimicrob Agents Chemother; 1999 Jan; 43(1):129-33. PubMed ID: 9869577 [Abstract] [Full Text] [Related]
13. Phagocytosis and intracellular killing of mucoid and nonmucoid variants of Pseudomonas aeruginosa by polymorphonuclear leukocytes: effect of specific immune sera. Gościniak G, Maresz-Babczyszyn J, Grzybek-Hryncewicz K. Arch Immunol Ther Exp (Warsz); 1984 Jan; 32(4):467-79. PubMed ID: 6442852 [Abstract] [Full Text] [Related]
14. Inhibition of polymorphonuclear leukocyte chemotaxis by the mucoid exopolysaccharide of Pseudomonas aeruginosa. Stiver HG, Zachidniak K, Speert DP. Clin Invest Med; 1988 Aug; 11(4):247-52. PubMed ID: 2971496 [Abstract] [Full Text] [Related]
15. Resistance of mucoid Pseudomonas aeruginosa to nonopsonic phagocytosis by alveolar macrophages in vitro. Krieg DP, Helmke RJ, German VF, Mangos JA. Infect Immun; 1988 Dec; 56(12):3173-9. PubMed ID: 3141284 [Abstract] [Full Text] [Related]
19. Alginate--its role in neutrophil responses and signal transduction towards mucoid Pseudomonas aeruginosa bacteria. König B, Friedl P, Pedersen SS, König W. Int Arch Allergy Immunol; 1992 Dec; 99(1):98-106. PubMed ID: 1336422 [Abstract] [Full Text] [Related]